@article{Balthasar1999,
   author = {Balthasar, Joseph P.},
   title = {Bioequivalence and Bioequivalency Testing},
   journal = {American Journal of Pharmaceutical Education},
   volume = {63},
   pages = {194-198},
   year = {1999},
   type = {Journal Article}
}

@article{Bego2022,
   author = {Bego, M. and Patel, N. and Cristofoletti, R. and Rostami-Hodjegan, A.},
   title = {Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling},
   journal = {AAPS J},
   volume = {24},
   number = {1},
   pages = {21},
   keywords = {Adolescent
Adult
Biological Availability
Cross-Over Studies
Delayed-Action Preparations
Gastrointestinal Tract/physiology
Humans
Male
Middle Aged
*Models, Biological
Proof of Concept Study
*Research Design
Therapeutic Equivalency
Triazoles/*administration & dosage/pharmacokinetics
Young Adult
intra-subject variation
physiology-based pharmacokinetics
virtual bioequivalence
within-subject variability},
   ISSN = {1550-7416 (Electronic)
1550-7416 (Linking)},
   DOI = {10.1208/s12248-021-00672-z},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/34988679},
   year = {2022},
   type = {Journal Article}
}

@article{Bi2018,
   author = {Bi, Y. and Perry, P. J. and Ellerby, M. and Murry, D. J.},
   title = {Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects},
   journal = {CPT Pharmacometrics Syst Pharmacol},
   volume = {7},
   number = {4},
   pages = {259-268},
   keywords = {Adult
Anabolic Agents/administration & dosage/blood/*pharmacology
Androgens/administration & dosage/blood/*pharmacology
Double-Blind Method
Healthy Volunteers
Humans
Luteinizing Hormone/blood
Male
*Models, Biological
Spermatogenesis/drug effects
Testosterone/administration & dosage/*analogs & derivatives/blood/pharmacology
Young Adult},
   ISSN = {2163-8306 (Electronic)
2163-8306 (Linking)},
   DOI = {10.1002/psp4.12287},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/29436172},
   year = {2018},
   type = {Journal Article}
}

@article{Bronaugh1986,
   author = {Bronaugh, R. L. and Franz, T. J.},
   title = {Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin},
   journal = {Br J Dermatol},
   volume = {115},
   number = {1},
   pages = {1-11},
   keywords = {Adult
Benzoates/administration & dosage
Benzoic Acid
Caffeine/administration & dosage
Ethylene Glycol
Ethylene Glycols/administration & dosage
Humans
In Vitro Techniques
Male
Pharmaceutical Vehicles/*pharmacology
Skin Absorption/*drug effects
Solubility
Testosterone/administration & dosage
Time Factors},
   ISSN = {0007-0963 (Print)
0007-0963 (Linking)},
   DOI = {10.1111/j.1365-2133.1986.tb06214.x},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/3730275},
   year = {1986},
   type = {Journal Article}
}

@book{Burnham2002,
   author = {Burnham, Kenneth P. and Anderson, David Raymond and Burnham, Kenneth P.},
   title = {Model selection and multimodel inference : a practical information-theoretic approach},
   publisher = {Springer},
   address = {New York},
   edition = {2nd},
   keywords = {Biology Mathematical models.
Mathematical statistics.},
   pages = {xxvi, 488 p.},
   ISBN = {0387953647 (alk. paper)},
   url = {Publisher description http://www.loc.gov/catdir/enhancements/fy0816/2001057677-d.html
Table of contents only http://www.loc.gov/catdir/enhancements/fy0816/2001057677-t.html},
   year = {2002},
   type = {Book}
}

@book{Chilukuri2007,
   author = {Chilukuri, Dakshina Murthy and Sunkara, Gangadhar and Young, David},
   title = {Pharmaceutical product development : in vitro-in vivo correlation},
   publisher = {Informa Healthcare},
   address = {New York},
   series = {Drugs and the pharmaceutical sciences},
   keywords = {Drug development.
Drugs Design.
Drug Design.
Biological Availability.
Drug Evaluation, Preclinical methods.},
   pages = {x, 204 p.},
   ISBN = {9780849338274 (alk. paper)
0849338271 (alk. paper)},
   url = {Publisher description http://www.loc.gov/catdir/enhancements/fy0703/2006050423-d.html},
   year = {2007},
   type = {Book}
}

@article{Chung2018,
   author = {Chung, I. and Oh, J. and Lee, S. and Jang, I. J. and Lee, Y. and Chung, J. Y.},
   title = {A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies},
   journal = {Transl Clin Pharmacol},
   volume = {26},
   number = {1},
   pages = {6-9},
   keywords = {bioequivalence
coefficient of variation
generic drugs
power
sample size},
   ISSN = {2383-5427 (Electronic)
2289-0882 (Print)
2289-0882 (Linking)},
   DOI = {10.12793/tcp.2018.26.1.6},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/32055541},
   year = {2018},
   type = {Journal Article}
}

@article{Connarn2017,
   author = {Connarn, J. N. and Flowers, S. and Kelly, M. and Luo, R. and Ward, K. M. and Harrington, G. and Moncion, I. and Kamali, M. and McInnis, M. and Feng, M. R. and Ellingrod, V. and Babiskin, A. and Zhang, X. and Sun, D.},
   title = {Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers},
   journal = {AAPS J},
   volume = {19},
   number = {5},
   pages = {1513-1522},
   keywords = {Adult
Bupropion/chemistry/*pharmacokinetics
Cross-Over Studies
Delayed-Action Preparations
Drug Compounding
Drug Liberation
Female
Healthy Volunteers
Humans
Male
Middle Aged
*Pharmacogenetics
Tablets
Therapeutic Equivalency
Cyp2b6
bioequivalence
bupropion
carbonyl reductase
metabolism},
   ISSN = {1550-7416 (Electronic)
1550-7416 (Linking)},
   DOI = {10.1208/s12248-017-0102-8},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/28685396},
   year = {2017},
   type = {Journal Article}
}

@article{Dancik2013,
   author = {Dancik, Y. and Miller, M. A. and Jaworska, J. and Kasting, G. B.},
   title = {Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure},
   journal = {Adv Drug Deliv Rev},
   volume = {65},
   number = {2},
   pages = {221-36},
   keywords = {Administration, Cutaneous
Biological Transport
Humans
*Models, Theoretical
Permeability
Pharmaceutical Preparations/administration & dosage/chemistry/*metabolism
Skin/metabolism
*Skin Absorption
Solubility},
   ISSN = {1872-8294 (Electronic)
0169-409X (Linking)},
   DOI = {10.1016/j.addr.2012.01.006},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/22285584},
   year = {2013},
   type = {Journal Article}
}

@article{Danielak2023,
   author = {Danielak, D. and Paszkowska, J. and Staniszewska, M. and Garbacz, G. and Terlecka, A. and Kubiak, B. and Romanski, M.},
   title = {Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug},
   journal = {Eur J Pharm Biopharm},
   volume = {186},
   pages = {132-143},
   keywords = {Therapeutic Equivalency
Retrospective Studies
Solubility
Drug Liberation
*Software
Computer Simulation
*Models, Biological
Bioequivalence
Biorelevant conditions, in-vitro-in-vivo predictions
Dissolution
Modeling
Population pharmacokinetics},
   ISSN = {1873-3441 (Electronic)
0939-6411 (Linking)},
   DOI = {10.1016/j.ejpb.2023.03.014},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/37015321},
   year = {2023},
   type = {Journal Article}
}

@article{Dhillon2008,
   author = {Dhillon, S. and Yang, L. P. and Curran, M. P.},
   title = {Spotlight on bupropion in major depressive disorder},
   journal = {CNS Drugs},
   volume = {22},
   number = {7},
   pages = {613-7},
   keywords = {Administration, Oral
Antidepressive Agents, Second-Generation/*therapeutic use
Bupropion/*therapeutic use
Depressive Disorder, Major/*drug therapy
Drug Administration Schedule
Drug Evaluation
Humans},
   ISSN = {1172-7047 (Print)
1172-7047 (Linking)},
   DOI = {10.2165/00023210-200822070-00006},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/18547129},
   year = {2008},
   type = {Journal Article}
}

@article{Fava2005,
   author = {Fava, M. and Rush, A. J. and Thase, M. E. and Clayton, A. and Stahl, S. M. and Pradko, J. F. and Johnston, J. A.},
   title = {15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL},
   journal = {Prim Care Companion J Clin Psychiatry},
   volume = {7},
   number = {3},
   pages = {106-13},
   ISSN = {1523-5998 (Print)
1523-5998 (Linking)},
   DOI = {10.4088/pcc.v07n0305},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/16027765},
   year = {2005},
   type = {Journal Article}
}

@misc{FDA21a,
   author = {Food and Drug Administration},
   title = {Code of Federal Regulations Title 21, 21CFR314.3},
   type = {Government Document}
}

@misc{FDA21b,
   author = {Food and Drug Administration},
   title = {Code of Federal Regulations Title 21, 21CFR320.21(b)(1)},
   type = {Government Document}
}

@misc{FDA505a,
   author = {Food and Drug Administration},
   title = {Federal Food, Drug, and Cosmetic Act (FD&C Act), 505(j)(8)(B)(i)},
   url = {https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act},
   type = {Government Document}
}

@misc{FDA505b,
   author = {Food and Drug Administration},
   title = {Federal Food, Drug, and Cosmetic Act (FD&C Act), section 505(j)(8)(B)(ii) and (C)},
   url = {https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act},
   type = {Government Document}
}

@misc{FDA2001,
   author = {Food and Drug Administration},
   title = {Statistical Approaches to Establishing Bioequivalence},
   ISBN = {01D-0027},
   year = {2001},
   type = {Government Document}
}

@misc{FDA2021,
   author = {Food and Drug Administration},
   title = {Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application},
   year = {2021},
   type = {Government Document}
}

@misc{FDA2022,
   author = {Food and Drug Administration},
   title = {Statistical Approaches to Establishing Bioequivalence},
   ISBN = {FDA-2001-D-0197},
   year = {2022},
   type = {Government Document}
}

@article{Golhar2023,
   author = {Golhar, A. and Pillai, M. and Dhakne, P. and Rajput, N. and Jadav, T. and Sengupta, P.},
   title = {Progressive tools and critical strategies for development of best fit PBPK model aiming better in vitro-in vivo correlation},
   journal = {Int J Pharm},
   volume = {643},
   pages = {123267},
   keywords = {Solubility
Administration, Oral
Drug Liberation
*Biopharmaceutics/methods
Gastrointestinal Tract/metabolism
*Biological Products/metabolism
Models, Biological
Computer Simulation
Dissolution
In vitro-In vivo correlation
Physiologically based biopharmaceutical modeling
Physiologically based pharmacokinetic modeling
Quality by design},
   ISSN = {1873-3476 (Electronic)
0378-5173 (Linking)},
   DOI = {10.1016/j.ijpharm.2023.123267},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/37488057},
   year = {2023},
   type = {Journal Article}
}

@article{Gong2023,
   author = {Gong, Y. and Zhang, P. and Yoon, M. and Zhu, H. and Kohojkar, A. and Hooker, A. C. and Ducharme, M. P. and Gobburu, J. and Celliere, G. and Gajjar, P. and Li, B. V. and Velagapudi, R. and Tsang, Y. C. and Schwendeman, A. and Polli, J. and Fang, L. and Lionberger, R. and Zhao, L.},
   title = {Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products: Summary of workshop},
   journal = {CPT Pharmacometrics Syst Pharmacol},
   volume = {12},
   number = {5},
   pages = {624-630},
   keywords = {United States
Humans
Therapeutic Equivalency
*Drugs, Generic
United States Food and Drug Administration
Computer Simulation},
   ISSN = {2163-8306 (Electronic)
2163-8306 (Linking)},
   DOI = {10.1002/psp4.12931},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/36710372},
   year = {2023},
   type = {Journal Article}
}

@misc{openVBE,
   author = {Hamadeh, A},
   title = {openVBE: A virtual bioequivalence toolbox for Open Systems Pharmacology Suite models},
   number = {29 March 2025},
   url = {https://github.com/Open-Systems-Pharmacology/OSPSuite.VBE-Toolbox},
   year = {2025},
   type = {Web Page}
}

@article{Hamadeh2023,
   author = {Hamadeh, A. and Nash, J. F. and Bialk, H. and Styczynski, P. and Troutman, J. and Edginton, A.},
   title = {Mechanistic Skin Modeling of Plasma Concentrations of Sunscreen Active Ingredients Following Facial Application},
   journal = {J Pharm Sci},
   keywords = {Dermal
Ivive
Mechanistic
Modeling
Pharmacokinetics
Sunscreen
UV filters},
   ISSN = {1520-6017 (Electronic)
0022-3549 (Linking)},
   DOI = {10.1016/j.xphs.2023.09.017},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/37769994},
   year = {2023},
   type = {Journal Article}
}

@misc{MoBiSkin2019,
   author = {Hamadeh, A. and Sevestre, M. and Edginton, A.},
   title = {Implementation of Dancik et al (2013) skin permeation model in MoBi},
   url = {https://github.com/Open-Systems-Pharmacology/Skin-permeation-model},
   year = {2019},
   type = {Electronic Article}
}

@article{Hamadeh2022,
   author = {Hamadeh, A. and Troutman, J. and Najjar, A. and Edginton, A.},
   title = {A Mechanistic Bayesian Inferential Workflow for Estimation of In Vivo Skin Permeation from In Vitro Measurements},
   journal = {J Pharm Sci},
   volume = {111},
   number = {3},
   pages = {838-851},
   keywords = {Bayesian
Dermal
Ivive
Mechanistic
Modeling
Pharmacokinetics},
   ISSN = {1520-6017 (Electronic)
0022-3549 (Linking)},
   DOI = {10.1016/j.xphs.2021.11.028},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/34871561},
   year = {2022},
   type = {Journal Article}
}

@article{Han2023,
   author = {Han, C. and Sun, T. and Chirumamilla, S. K. and Bois, F. Y. and Xu, M. and Rostami-Hodjegan, A.},
   title = {Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn's Disease Patients through PBPK Modeling},
   journal = {Pharmaceutics},
   volume = {15},
   number = {9},
   keywords = {Entocort EC
f2
gut-wall exposure
local BE
local bioequivalence
virtual bioequivalence},
   ISSN = {1999-4923 (Print)
1999-4923 (Electronic)
1999-4923 (Linking)},
   DOI = {10.3390/pharmaceutics15092237},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/37765205},
   year = {2023},
   type = {Journal Article}
}

@article{Han2022,
   author = {Han, M. and Xu, J. and Lin, Y.},
   title = {Approaches of formulation bridging in support of orally administered drug product development},
   journal = {Int J Pharm},
   volume = {629},
   pages = {122380},
   keywords = {*Drug Development
*Biopharmaceutics
Solubility
Models, Biological
Therapeutic Equivalency
Bioequivalence
Biopharmaceutics
Biowaiver
Formulation bridging
Relative bioavailability},
   ISSN = {1873-3476 (Electronic)
0378-5173 (Linking)},
   DOI = {10.1016/j.ijpharm.2022.122380},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/36368608},
   year = {2022},
   type = {Journal Article}
}

@article{Heimbach2021,
   author = {Heimbach, T. and Kesisoglou, F. and Novakovic, J. and Tistaert, C. and Mueller-Zsigmondy, M. and Kollipara, S. and Ahmed, T. and Mitra, A. and Suarez-Sharp, S.},
   title = {Establishing the Bioequivalence Safe Space for Immediate-Release Oral Dosage Forms using Physiologically Based Biopharmaceutics Modeling (PBBM): Case Studies},
   journal = {J Pharm Sci},
   volume = {110},
   number = {12},
   pages = {3896-3906},
   keywords = {Administration, Oral
*Biopharmaceutics/methods
Dosage Forms
Drug Liberation
*Models, Biological
Solubility
Therapeutic Equivalency
Bioavailability
Bioequivalence
Biopharmaceutics
Dissolution model(s)
In Vitro-In Vivo Correlation(s) (IVIVC)
Particle size
Physiologically Based Pharmacokinetic (PBPK) modeling},
   ISSN = {1520-6017 (Electronic)
0022-3549 (Linking)},
   DOI = {10.1016/j.xphs.2021.09.017},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/34551349},
   year = {2021},
   type = {Journal Article}
}

@article{Hilton1994,
   author = {Hilton, J. and Woollen, B. H. and Scott, R. C. and Auton, T. R. and Trebilcock, K. L. and Wilks, M. F.},
   title = {Vehicle effects on in vitro percutaneous absorption through rat and human skin},
   journal = {Pharm Res},
   volume = {11},
   number = {10},
   pages = {1396-400},
   keywords = {Animals
Decanoates/chemistry/pharmacology
Humans
In Vitro Techniques
Kinetics
Octanols/chemistry/pharmacology
Pharmaceutical Vehicles/chemistry/*pharmacology
Propylene Glycols/chemistry/pharmacology
Rats
Rats, Inbred Strains
Rats, Sprague-Dawley
Skin Absorption/*drug effects
Solubility
Species Specificity},
   ISSN = {0724-8741 (Print)
0724-8741 (Linking)},
   DOI = {10.1023/a:1018931503784},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/7855041},
   year = {1994},
   type = {Journal Article}
}

@article{Hsieh2021,
   author = {Hsieh, N. H. and Bois, F. Y. and Tsakalozou, E. and Ni, Z. and Yoon, M. and Sun, W. and Klein, M. and Reisfeld, B. and Chiu, W. A.},
   title = {A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage forms},
   journal = {J Pharmacokinet Pharmacodyn},
   volume = {48},
   number = {6},
   pages = {893-908},
   keywords = {Administration, Oral
Bayes Theorem
Biological Availability
*Bupropion
*Drugs, Generic
Humans
Models, Biological
Tablets/pharmacokinetics
Therapeutic Equivalency
Bayesian inference
Bioequivalence
Bupropion hydrochloride
Generic drug
Physiologically based pharmacokinetic model
Population pharmacokinetics},
   ISSN = {1573-8744 (Electronic)
1567-567X (Print)
1567-567X (Linking)},
   DOI = {10.1007/s10928-021-09778-5},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/34553275},
   year = {2021},
   type = {Journal Article}
}

@article{Hu2004,
   author = {Hu, C. and Moore, K. H. and Kim, Y. H. and Sale, M. E.},
   title = {Statistical issues in a modeling approach to assessing bioequivalence or PK similarity with presence of sparsely sampled subjects},
   journal = {J Pharmacokinet Pharmacodyn},
   volume = {31},
   number = {4},
   pages = {321-39},
   keywords = {Area Under Curve
Humans
Models, Biological
Monte Carlo Method
*Pharmacokinetics
*Therapeutic Equivalency},
   ISSN = {1567-567X (Print)
1567-567X (Linking)},
   DOI = {10.1023/b:jopa.0000042739.44458.e0},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/15563006},
   year = {2004},
   type = {Journal Article}
}

@article{Julious2004,
   author = {Julious, S. A.},
   title = {Sample sizes for clinical trials with normal data},
   journal = {Stat Med},
   volume = {23},
   number = {12},
   pages = {1921-86},
   keywords = {Biometry/*methods
Cross-Over Studies
Humans
Randomized Controlled Trials as Topic/*methods
Research Design
Sample Size
Therapeutic Equivalency},
   ISSN = {0277-6715 (Print)
0277-6715 (Linking)},
   DOI = {10.1002/sim.1783},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/15195324},
   year = {2004},
   type = {Journal Article}
}

@article{Kollipara2024,
   author = {Kollipara, S. and Martins, F. S. and Jereb, R. and Krajcar, D. and Ahmed, T.},
   title = {Advancing Virtual Bioequivalence for Orally Administered Drug Products: Methodology, Real-World Applications and Future Outlook},
   journal = {Pharmaceuticals (Basel)},
   volume = {17},
   number = {7},
   keywords = {GastroPlus
Pbbm
regulatory
variability
virtual bioequivalence},
   ISSN = {1424-8247 (Print)
1424-8247 (Electronic)
1424-8247 (Linking)},
   DOI = {10.3390/ph17070876},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/39065727},
   year = {2024},
   type = {Journal Article}
}

@article{Lehman2011,
   author = {Lehman, P. A. and Raney, S. G. and Franz, T. J.},
   title = {Percutaneous absorption in man: in vitro-in vivo correlation},
   journal = {Skin Pharmacol Physiol},
   volume = {24},
   number = {4},
   pages = {224-30},
   keywords = {Humans
Male
Pharmaceutical Vehicles/pharmacokinetics
*Pharmacokinetics
Skin/*metabolism
*Skin Absorption
Statistics as Topic},
   ISSN = {1660-5535 (Electronic)
1660-5527 (Linking)},
   DOI = {10.1159/000324884},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/21455015},
   year = {2011},
   type = {Journal Article}
}

@article{Lippert2019,
   author = {Lippert, J. and Burghaus, R. and Edginton, A. and Frechen, S. and Karlsson, M. and Kovar, A. and Lehr, T. and Milligan, P. and Nock, V. and Ramusovic, S. and Riggs, M. and Schaller, S. and Schlender, J. and Schmidt, S. and Sevestre, M. and Sjogren, E. and Solodenko, J. and Staab, A. and Teutonico, D.},
   title = {Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences},
   journal = {CPT Pharmacometrics Syst Pharmacol},
   volume = {8},
   number = {12},
   pages = {878-882},
   keywords = {Access to Information
Computer Simulation
Humans
Pharmacology, Clinical/*methods
Systems Biology},
   ISSN = {2163-8306 (Electronic)
2163-8306 (Linking)},
   DOI = {10.1002/psp4.12473},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/31671256},
   year = {2019},
   type = {Journal Article}
}

@article{Loisios2020,
   author = {Loisios-Konstantinidis, I. and Cristofoletti, R. and Fotaki, N. and Turner, D. B. and Dressman, J.},
   title = {Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen},
   journal = {Eur J Pharm Sci},
   volume = {143},
   pages = {105170},
   keywords = {Administration, Intravenous
Administration, Oral
Adolescent
Adult
Anti-Inflammatory Agents, Non-Steroidal/*chemistry/*pharmacokinetics
Biological Availability
Clinical Trials as Topic
*Drug Liberation
Female
Humans
Male
Middle Aged
*Models, Biological
Naproxen/*chemistry/*pharmacokinetics
Solubility
Therapeutic Equivalency
Young Adult
Biorelevant dissolution
Clinically relevant specifications
Dissolution safe-space
Ivive
Modeling & simulation
Pbpk
Virtual bioequivalence},
   ISSN = {1879-0720 (Electronic)
0928-0987 (Linking)},
   DOI = {10.1016/j.ejps.2019.105170},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/31783158},
   year = {2020},
   type = {Journal Article}
}

@article{Mackie2024,
   author = {Mackie, C. and Arora, S. and Seo, P. and Moody, R. and Rege, B. and Pepin, X. and Heimbach, T. and Tannergren, C. and Mitra, A. and Suarez-Sharp, S. and Borges, L. N. and Kijima, S. and Kotzagiorgis, E. and Malamatari, M. and Veerasingham, S. and Polli, J. E. and Rullo, G.},
   title = {Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report},
   journal = {Mol Pharm},
   volume = {21},
   number = {5},
   pages = {2065-2080},
   keywords = {Humans
*Biopharmaceutics/methods
*Drug Industry/methods
Models, Biological
Therapeutic Equivalency
Pharmaceutical Preparations/chemistry
United States
MIDD (model informed drug development)
PBBM (physiologically based biopharmaceutics model(s)(ing)
PBPK (physiologically based pharmacokinetics)
biopredictive dissolution
clinically relevant dissolution specifications (CRDS)
drug product performance
drug product quality
patient-centric drug product quality standards
safe space
virtual bioequivalence (VBE)},
   ISSN = {1543-8392 (Electronic)
1543-8384 (Print)
1543-8384 (Linking)},
   DOI = {10.1021/acs.molpharmaceut.4c00202},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/38600804},
   year = {2024},
   type = {Journal Article}
}

@article{Madabushi2022,
   author = {Madabushi, R. and Seo, P. and Zhao, L. and Tegenge, M. and Zhu, H.},
   title = {Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making},
   journal = {Pharm Res},
   volume = {39},
   number = {8},
   pages = {1669-1680},
   keywords = {Animals
Drug Approval
*Drug Development
*Drugs, Generic
Humans
Life Cycle Stages
Pharmaceutical Preparations
United States
United States Food and Drug Administration
biopharmaceutics
gene therapy
generic drugs
model-informed drug development
new drugs},
   ISSN = {1573-904X (Electronic)
0724-8741 (Print)
0724-8741 (Linking)},
   DOI = {10.1007/s11095-022-03288-w},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/35552984},
   year = {2022},
   type = {Journal Article}
}

@article{Marok2021,
   author = {Marok, F. Z. and Fuhr, L. M. and Hanke, N. and Selzer, D. and Lehr, T.},
   title = {Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network},
   journal = {Pharmaceutics},
   volume = {13},
   number = {3},
   keywords = {bupropion
cytochrome P450 2B6 (CYP2B6)
drug-drug-interactions (DDIs)
drug-gene-interactions (DGIs)
hydroxybupropion
physiologically based pharmacokinetic modeling},
   ISSN = {1999-4923 (Print)
1999-4923 (Electronic)
1999-4923 (Linking)},
   DOI = {10.3390/pharmaceutics13030331},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/33806634},
   year = {2021},
   type = {Journal Article}
}

@article{Matta2020,
   author = {Matta, M. K. and Florian, J. and Zusterzeel, R. and Pilli, N. R. and Patel, V. and Volpe, D. A. and Yang, Y. and Oh, L. and Bashaw, E. and Zineh, I. and Sanabria, C. and Kemp, S. and Godfrey, A. and Adah, S. and Coelho, S. and Wang, J. and Furlong, L. A. and Ganley, C. and Michele, T. and Strauss, D. G.},
   title = {Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial},
   journal = {JAMA},
   volume = {323},
   number = {3},
   pages = {256-267},
   keywords = {Acrylates/blood/pharmacokinetics
Adult
Benzophenones/blood/pharmacokinetics
Cinnamates/blood/pharmacokinetics
Female
Humans
Male
Middle Aged
Propiophenones/*blood/pharmacokinetics
Salicylates/blood/pharmacokinetics
*Skin Absorption
Sunscreening Agents/adverse effects/*pharmacokinetics},
   ISSN = {1538-3598 (Electronic)
0098-7484 (Print)
0098-7484 (Linking)},
   DOI = {10.1001/jama.2019.20747},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/31961417},
   year = {2020},
   type = {Journal Article}
}

@article{Miao2020,
   author = {Miao, L. and Mousa, Y. M. and Zhao, L. and Raines, K. and Seo, P. and Wu, F.},
   title = {Using a Physiologically Based Pharmacokinetic Absorption Model to Establish Dissolution Bioequivalence Safe Space for Oseltamivir in Adult and Pediatric Populations},
   journal = {AAPS J},
   volume = {22},
   number = {5},
   pages = {107},
   keywords = {Absorption, Physiological
Adult
Antiviral Agents/*pharmacokinetics
Child
Humans
*Models, Theoretical
Oseltamivir/*pharmacokinetics
Therapeutic Equivalency
bioequivalence
dissolution
oseltamivir
pediatric
physiologically based pharmacokinetic absorption model},
   ISSN = {1550-7416 (Electronic)
1550-7416 (Linking)},
   DOI = {10.1208/s12248-020-00493-6},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/32779046},
   year = {2020},
   type = {Journal Article}
}

@misc{NHANES1997,
   author = {National Center for Health Statistics Hyattsville (NHANES III)},
   title = {Third National Health and Nutrition Examination Survey},
   url = {http://www.cdc.gov/nchs/nhanes.htm},
   year = {1997},
   type = {Web Page}
}

@article{Nguyen2017,
   author = {Nguyen, M. A. and Flanagan, T. and Brewster, M. and Kesisoglou, F. and Beato, S. and Biewenga, J. and Crison, J. and Holm, R. and Li, R. and Mannaert, E. and McAllister, M. and Mueller-Zsigmondy, M. and Muenster, U. and Ojala, K. and Page, S. and Parr, A. and Rossenu, S. and Timmins, P. and Van Peer, A. and Vermeulen, A. and Langguth, P.},
   title = {A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives},
   journal = {Eur J Pharm Sci},
   volume = {102},
   pages = {1-13},
   keywords = {Animals
*Drug Discovery
*Drug Industry
Humans
*Models, Biological
Pharmacokinetics
Surveys and Questionnaires
Dissolution
In vitro/in vivo correlation
Modelling and simulation
Oral dosage forms
Regulatory},
   ISSN = {1879-0720 (Electronic)
0928-0987 (Linking)},
   DOI = {10.1016/j.ejps.2017.02.029},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/28235611},
   year = {2017},
   type = {Journal Article}
}

@misc{OECD2022,
   author = {OECD},
   title = {Guidance Notes On Dermal Absorption Studies, Series on Testing and Assessment},
   publisher = {Environment, Health and Safety Publications, },
   year = {2022},
   type = {Generic}
}

@article{Pal2024,
   author = {Pal, A. and Wu, F. and Walenga, R. and Tsakalozou, E. and Alam, K. and Gong, Y. and Zhao, L. and Fang, L.},
   title = {Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public Workshop},
   journal = {AAPS J},
   volume = {26},
   number = {3},
   pages = {45},
   keywords = {United States
*Drugs, Generic
Therapeutic Equivalency
*Artificial Intelligence
Drug Development
United States Food and Drug Administration
bioequivalence
inhaled products
long-acting injectable products
modeling and simulation
orally
topical products},
   ISSN = {1550-7416 (Electronic)
1550-7416 (Linking)},
   DOI = {10.1208/s12248-024-00916-8},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/38589695},
   year = {2024},
   type = {Journal Article}
}

@article{Paraiso2020,
   author = {Paraiso, R. L. M. and Rose, R. H. and Fotaki, N. and McAllister, M. and Dressman, J. B.},
   title = {The use of PBPK/PD to establish clinically relevant dissolution specifications for zolpidem immediate release tablets},
   journal = {Eur J Pharm Sci},
   volume = {155},
   pages = {105534},
   keywords = {*Hypnotics and Sedatives
Solubility
Tablets
Therapeutic Equivalency
Zolpidem
Clinical relevant dissolution specification
Food effect
Pbpk
Pbpk/pd},
   ISSN = {1879-0720 (Electronic)
0928-0987 (Linking)},
   DOI = {10.1016/j.ejps.2020.105534},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/32871212},
   year = {2020},
   type = {Journal Article}
}

@article{Pathak2017,
   author = {Pathak, S. M. and Ruff, A. and Kostewicz, E. S. and Patel, N. and Turner, D. B. and Jamei, M.},
   title = {Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug},
   journal = {Mol Pharm},
   volume = {14},
   number = {12},
   pages = {4305-4320},
   keywords = {Absorption, Physiological
Administration, Oral
Biopharmaceutics/methods
Chemistry, Pharmaceutical
Computer Simulation
*Drug Liberation
Humans
Intestinal Absorption/*physiology
Ketoconazole/*pharmacokinetics
*Models, Biological
Models, Chemical
Permeability
Solubility
Iviv_e
Pbpk
biopharmaceutics
dissolution modeling
ketoconazole
pharmacokinetics
precipitation},
   ISSN = {1543-8392 (Electronic)
1543-8384 (Linking)},
   DOI = {10.1021/acs.molpharmaceut.7b00406},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/28771009},
   year = {2017},
   type = {Journal Article}
}

@article{Pepin2019,
   author = {Pepin, X. J. H. and Sanderson, N. J. and Blanazs, A. and Grover, S. and Ingallinera, T. G. and Mann, J. C.},
   title = {Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part I. Mechanistic modelling of drug product dissolution to derive a P-PSD for PBPK model input},
   journal = {Eur J Pharm Biopharm},
   volume = {142},
   pages = {421-434},
   keywords = {Benzamides/*chemistry
Capsules/chemistry
Drug Liberation/*drug effects
Micelles
Models, Biological
Particle Size
Pyrazines/*chemistry
Solubility/*drug effects
Dissolution
Drug product
Mechanistic
PBPK modelling
Prediction
Surface pH
Weak base},
   ISSN = {1873-3441 (Electronic)
0939-6411 (Linking)},
   DOI = {10.1016/j.ejpb.2019.07.014},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/31306753},
   year = {2019},
   type = {Journal Article}
}

@article{Purohit2024,
   author = {Purohit, V. and Sagawa, K. and Hsu, H. J. and Kushner, J. and Dowty, M. E. and Tse, S. and Lin, J. and Blanchard, A. and Mukherjee, A. and Le, V. and Chang, C.},
   title = {Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage Form},
   journal = {Clin Pharmacol Ther},
   volume = {116},
   number = {4},
   pages = {996-1004},
   keywords = {Humans
*Piperidines/pharmacokinetics/administration & dosage
*Pyrimidines/pharmacokinetics/administration & dosage
*Models, Biological
*Therapeutic Equivalency
Male
*Microspheres
Adult
Delayed-Action Preparations
Female
Young Adult
Pyrroles/pharmacokinetics/administration & dosage
Adolescent
Protein Kinase Inhibitors/pharmacokinetics/administration & dosage
Drug Administration Schedule
Middle Aged
Janus Kinase Inhibitors/pharmacokinetics/administration & dosage
Computer Simulation
Cross-Over Studies
Tablets},
   ISSN = {1532-6535 (Electronic)
0009-9236 (Linking)},
   DOI = {10.1002/cpt.3313},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/38797995},
   year = {2024},
   type = {Journal Article}
}

@article{Tannergren2025,
   author = {Tannergren, C. and Arora, S. and Babiskin, A. and Borges, L. and Chatterjee, P. and Cheng, Y. H. and Dallmann, A. and Govada, A. and Heimbach, T. and Hingle, M. and Kollipara, S. and Kotzagiorgis, E. and Lindahl, A. and Mackie, C. and Malamatari, M. and Mitra, A. and Moody, R. and Pepin, X. and Polli, J. and Raines, K. and Rullo, G. and Sanghavi, M. and Savkur, R. and Singh, R. and Sjogren, E. and Suarez-Sharp, S. and Thomas, S. and Veerasingham, S. and Wei, K. and Wu, F. and Xu, Y. and Yoon, M. and Rege, B.},
   title = {Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report},
   journal = {Mol Pharm},
   volume = {22},
   number = {1},
   pages = {5-27},
   keywords = {Humans
*Biopharmaceutics/methods
Delayed-Action Preparations/pharmacokinetics
Drug Development/methods
Drugs, Generic/pharmacokinetics
Models, Biological
*Therapeutic Equivalency
Congresses as Topic
PBBM (physiologically based biopharmaceutics modeling)
PBPK (physiologically based pharmacokinetics)
clinically relevant dissolution specifications (CRDS)
dissolution safe space
drug product quality
generic product development
patient centric drug product quality standards
regulatory applications
virtual bioequivalence (VBE)},
   ISSN = {1543-8392 (Electronic)
1543-8384 (Print)
1543-8384 (Linking)},
   DOI = {10.1021/acs.molpharmaceut.4c01148},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/39680866},
   year = {2025},
   type = {Journal Article}
}

@article{Tsakalozou2021,
   author = {Tsakalozou, E. and Babiskin, A. and Zhao, L.},
   title = {Physiologically-based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1},
   journal = {CPT Pharmacometrics Syst Pharmacol},
   volume = {10},
   number = {5},
   pages = {399-411},
   keywords = {Administration, Cutaneous
Anti-Inflammatory Agents, Non-Steroidal/administration &
dosage/blood/metabolism/*pharmacokinetics
Diclofenac/administration & dosage/blood/metabolism/*pharmacokinetics
Humans
*Models, Biological
Skin/metabolism
*Therapeutic Equivalency},
   ISSN = {2163-8306 (Electronic)
2163-8306 (Linking)},
   DOI = {10.1002/psp4.12600},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/33547863},
   year = {2021},
   type = {Journal Article}
}

@article{vanBorselen2024,
   author = {van Borselen, M. D. and Sluijterman, Laae and Greupink, R. and de Wildt, S. N.},
   title = {Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care},
   journal = {Clin Pharmacokinet},
   volume = {63},
   number = {3},
   pages = {343-355},
   keywords = {Adult
Humans
*Midazolam/pharmacokinetics
Confidence Intervals
*Models, Biological
Computer Simulation
Software},
   ISSN = {1179-1926 (Electronic)
0312-5963 (Print)
0312-5963 (Linking)},
   DOI = {10.1007/s40262-023-01326-3},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/38361163},
   year = {2024},
   type = {Journal Article}
}

@article{Wang2024,
   author = {Wang, M. and Heimbach, T. and Zhu, W. and Wu, D. and Reuter, K. G. and Kesisoglou, F.},
   title = {Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space},
   journal = {AAPS J},
   volume = {26},
   number = {4},
   pages = {69},
   keywords = {*Therapeutic Equivalency
Humans
*Models, Biological
*Solubility
Proton Pump Inhibitors/pharmacokinetics/administration & dosage/chemistry
Biological Availability
Biopharmaceutics/methods
Drug Liberation
Omeprazole/pharmacokinetics/administration & dosage/chemistry
Administration, Oral
Hydrogen-Ion Concentration
Tablets
Drug Interactions
Chemistry, Pharmaceutical/methods
Cross-Over Studies
Drug Compounding/methods
GastroPlus
IR formulation selection
bioequivalence safe space
biopharmaceutics
dissolution specification
gefapixant
pharmacokinetics
physiologically based biopharmaceutics model(s)(ing) (PBBM)},
   ISSN = {1550-7416 (Electronic)
1550-7416 (Linking)},
   DOI = {10.1208/s12248-024-00938-2},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/38862807},
   year = {2024},
   type = {Journal Article}
}

@article{Wu2024,
   author = {Wu, F. and Mousa, Y. and Jereb, R. and Batchelor, H. and Chakraborty, S. and Heimbach, T. and Stier, E. and Kesisoglou, F. and Kollipara, S. and Zhang, L. and Zhao, L.},
   title = {Using Mechanistic Modeling Approaches to Support Bioequivalence Assessments for Oral Products},
   journal = {AAPS J},
   volume = {26},
   number = {1},
   pages = {19},
   keywords = {United States
Therapeutic Equivalency
Computer Simulation
*Drug Development
*Drugs, Generic
United States Food and Drug Administration
absorption
mechanistic modeling
oral products
virtual bioequivalence},
   ISSN = {1550-7416 (Electronic)
1550-7416 (Linking)},
   DOI = {10.1208/s12248-024-00886-x},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/38267737},
   year = {2024},
   type = {Journal Article}
}

@article{Yamada2020,
   author = {Yamada, W. M. and Neely, M. N. and Bartroff, J. and Bayard, D. S. and Burke, J. V. and Guilder, M. V. and Jelliffe, R. W. and Kryshchenko, A. and Leary, R. and Tatarinova, T. and Schumitzky, A.},
   title = {An Algorithm for Nonparametric Estimation of a Multivariate Mixing Distribution with Applications to Population Pharmacokinetics},
   journal = {Pharmaceutics},
   volume = {13},
   number = {1},
   keywords = {adaptive grid
high dimensional statistics
mixture distribution
mixture model
nonparametric maximum likelihood
population model
primal-dual interior-point method},
   ISSN = {1999-4923 (Print)
1999-4923 (Electronic)
1999-4923 (Linking)},
   DOI = {10.3390/pharmaceutics13010042},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/33396749},
   year = {2020},
   type = {Journal Article}
}

@article{Yu2021,
   author = {Yu, F. and Tonnis, K. and Kasting, G. B. and Jaworska, J.},
   title = {Computer Simulation of Skin Permeability of Hydrophobic and Hydrophilic Chemicals - Influence of Follicular Pathway},
   journal = {J Pharm Sci},
   volume = {110},
   number = {5},
   pages = {2149-2156},
   keywords = {Administration, Cutaneous
Computer Simulation
Diffusion
*Models, Biological
Permeability
Skin/metabolism
*Skin Absorption
*Absorption
*Biophysical models
*Disposition
*Mathematical model
*Passive diffusion/transport
*Pathways
*Percutaneous
*Permeability
*Skin
*Transdermal},
   ISSN = {1520-6017 (Electronic)
0022-3549 (Linking)},
   DOI = {10.1016/j.xphs.2020.12.020},
   url = {https://www.ncbi.nlm.nih.gov/pubmed/33359309},
   year = {2021},
   type = {Journal Article}
}

